Cardiol Therapeutics Inc. (TSX:CRDL)
1.830
-0.020 (-1.08%)
Aug 15, 2025, 4:00 PM EDT
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2024. The number of employees increased by 12 or 200.00% compared to the previous year.
Employees
18
Change
12
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-2.09M CAD
Market Cap
152.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18 | 12 | 200.00% |
Dec 31, 2018 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Curaleaf Holdings | 5,519 |
Green Thumb Industries | 4,800 |
Trulieve Cannabis | 6,000 |
Sienna Senior Living | 12,263 |
dentalcorp Holdings | 10,200 |
Cronos Group | 459 |
WELL Health Technologies | 1,507 |
Extendicare | 23,000 |
Cardiol Therapeutics News
- 4 days ago - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference - Newsfile Corp
- 9 days ago - Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Newsfile Corp
- 24 days ago - Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile Corp
- 2 months ago - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors - Newsfile Corp
- 4 months ago - Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Newsfile Corp
- 4 months ago - Cardiol Therapeutics Announces Year-End 2024 Update on Operations - Newsfile Corp